Zobrazeno 1 - 10 of 18 pro vyhledávání: '"A B Kilgallen"'
1
Akademický článek
Circadian Dependence of the Acute Immune Response to Myocardial Infarction
Autor: Aoife B. Kilgallen, Frederieke van den Akker, Dries A. M. Feyen, Sandra Crnko, Christian J. B. Snijders Blok, Hendrik Gremmels, Bastiaan C. du Pré, Robin Reijers, Pieter A. Doevendans, Saskia C. A. de Jager, Joost P. G. Sluijter, Vasco Sampaio-Pinto, Linda W. van Laake
Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)
Circadian rhythms influence the recruitment of immune cells and the onset of inflammation, which is pivotal in the response to ischemic cardiac injury after a myocardial infarction (MI). The hyperacute immune response that occurs within the first few
Externí odkaz: https://doaj.org/article/2c8d8f8f5bf5497ca023fd74c4cb118c
Zobrazit plný text záznamu
2
Circadian dependence of the acute immune response to myocardial infarction
Autor: L. W. van Laake, B C Du Pre, Hendrik Gremmels, Sandra Crnko, V M Sampiao Pinto, J. P. G. Sluijter, A B Kilgallen, S.C.A. de Jager, Dries A.M. Feyen, R Reijers, F Van Der Akker, P. A. F. M. Doevendans
Publikováno v: European Heart Journal. 42
Aim Circadian rhythms control many physiological processes, including numerous aspects of the immune system. Whether these immunological oscillations play a role in the pathophysiology after ischemic injury, such as myocardial infarction (MI), remain
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5d2973ab14278c00cbaceba9a63dbef
https://doi.org/10.1093/eurheartj/ehab724.3232
Zobrazit plný text záznamu
3
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World Use
Autor: Thasia G. Woodworth, C. Stach, Daniel E. Furst, Victor S. Sloan, B. Kilgallen
Publikováno v: Drug Safety. 42:1499-1506
The Outcome Measures in Rheumatology Clinical Trials (OMERACT) Rheumatology Common Toxicity Criteria (RCTC) version 2.0 was published in 2007 by the OMERACT Drug Safety Working Group, building on limited experience with RCTC version 1.0, to facilitat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85d55e0a6f419a4d6a6b6c036d64d8b
https://doi.org/10.1007/s40264-019-00864-9
Zobrazit plný text záznamu
4
A Fifty-Two–Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis
Autor: Robert Landewé, Lars Bauer, Jonathan Kay, Martin Rudwaleit, B. Kilgallen, Atul Deodhar, Walter P. Maksymowych, Nigil Haroon, Désirée van der Heijde, Bengt Hoepken, Lianne S. Gensler, Stephen Hall, Natasha de Peyrecave
Publikováno v: Arthritis & rheumatology (Hoboken, N.J.), vol 71, iss 7
Arthritis and Rheumatology, 71(7), 1101-1111. WILEY
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & rheumatology (Hoboken, N.J.), 71(7), 1101-1111. John Wiley and Sons Ltd
Author(s): Deodhar, Atul; Gensler, Lianne S; Kay, Jonathan; Maksymowych, Walter P; Haroon, Nigil; Landewe, Robert; Rudwaleit, Martin; Hall, Stephen; Bauer, Lars; Hoepken, Bengt; de Peyrecave, Natasha; Kilgallen, Brian; van der Heijde, Desiree | Abstr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e397f6bddda93e2815370c96b15710
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067972534&origin=inward
Zobrazit plný text záznamu
5
Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
Autor: Sonja Levy, Aoife B. Kilgallen, Catharina M. Korse, Marish I. F. J. Oerlemans, Joost P. G. Sluijter, Linda W. van Laake, Gerlof D. Valk, Margot E. T. Tesselaar
Publikováno v: Cancers; Volume 14; Issue 10; Pages: 2361
Carcinoid heart disease (CHD) is a rare fibrotic cardiac complication of neuroendocrine tumors. Besides known biomarkers N-Terminal pro-B-type natriuretic peptide (NT-proBNP) and serotonin, activin A, connective tissue growth factor (CTGF), and solub
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fdc857f9c7e1fe9964902274f4354ba
https://doi.org/10.3390/cancers14102361
Zobrazit plný text záznamu
6
Influence of mental stress and environmental toxins on circadian clocks : implications for redox regulation of the heart and cardioprotection
Autor: Thomas Münzel, Huige Li, Rainer Schulz, Aoife B. Kilgallen, Andreas Daiber, Eva Wolf, Sandrine Lecour, Linda W. van Laake
Publikováno v: British Journal of Pharmacology
Risk factors in the environment such as air pollution and mental stress contribute to the development of chronic non-communicable disease. Air pollution was identified as the leading health risk factor in the physical environment, followed by water p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec9e6e984df583d3a0a2217c51e7121
Zobrazit plný text záznamu
7
Oral abstracts 1: SpondyloarthropathiesO1. Detecting axial spondyloarthritis amongst primary care back pain referrals
Autor: C. Harris, D. Remedios, T. Aptowitzer, A. Keat, L. Hamilton, G. Guile, A. Belkhiri, D. Newman, A. Toms, A. Macgregor, K. Gaffney, L. Morton, G. T. Jones, A. G. MacDonald, C. Downham, G. J. Macfarlane, W. Tillett, D. Jadon, D. Wallis, L. Costa, N. Waldron, N. Griffith, C. Cavill, E. Korendowych, C. de Vries, N. McHugh, O. Iaremenko, D. Fedkov, P. Emery, D. Baeten, J. Sieper, J. Braun, D. van der Heijde, I. McInnes, J. Van Laar, R. Landewe, B. P. Wordsworth, J. Wollenhaupt, H. Kellner, I. Paramarta, A. Bertolino, A. M. Wright, W. Hueber, N. Sofat, C. Smee, M. Hermansson, J. Wajed, K. Sanyal, P. Kiely, M. Howard, F. A. Howe, T. R. Barrick, A. M. Abraham, M. S. Pearce, K. D. Mann, R. M. Francis, F. Birrell, A. Carr, I. Macleod, W.-F. Ng, A. Kavanaugh, C. Chattopadhyay, D. Gladman, P. Mease, G. Krueger, W. Xu, N. Goldstein, A. Beutler, X. Baraliakos, D. D. Laurent, S. Gsteiger, P. G. Conaghan, C. G. Peterfy, J. DiCarlo, E. Olech, A. R. Alberts, J. A. Alper, J. Devenport, A. M. Anisfeld, O. M. Troum, P. Cooper, M. Gimpel, G. Deakin, K. Jameson, M. Godtschailk, S. Gadola, M. Stokes, C. Cooper, C. Gordon, K. Kalunian, M. Petri, V. Strand, B. Kilgallen, A. Barry, D. Wallace, C. A. Flurey, M. Morris, J. Pollock, R. Hughes, P. Richards, S. Hewlett
Background: Inflammatory back pain (IBP) is an early feature of ankylosing spondylitis (AS) and its detection offers the prospect of early diagnosis of AS. However, since back pain is very common but only a very small minority of back pain sufferers
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7966cef50559cc7ce7e54c88ea8e92b7
http://doc.rero.ch/record/290228/files/kes118.pdf
Zobrazit plný text záznamu
8
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006
Autor: B. Kilgallen, William A. Wegener, Kenneth C. Kalunian, David M. Goldenberg, Caroline Gordon, Daniel J. Wallace, Vibeke Strand, Kathryn Hobbs, Lexy Kelley, Michelle Petri
Publikováno v: Rheumatology (Oxford, England)
Rheumatology (Oxford, England), vol 53, iss 3
Objective. To evaluate health-related quality of life (HRQOL) and corticosteroid use in patients with moderate to severely active SLE enrolled in two international, multicentre, randomized controlled trials of epratuzumab (ALLEVIATE-1 and -2) and a l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec0cb0d662da6d92692206427173812
http://europepmc.org/articles/PMC3930886
Zobrazit plný text záznamu
9
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study
Autor: D J, Wallace, K, Hobbs, M E B, Clowse, M, Petri, V, Strand, M, Pike, J T, Merrill, P, Leszczyński, C M, Neuwelt, S, Jeka, F, Houssiau, M, Keiserman, J, Ordi-Ros, S, Bongardt, B, Kilgallen, C, Galateanu, K, Kalunian, R, Furie, C, Gordon
Publikováno v: Arthritis careresearch. 68(4)
The primary objective was to assess the long-term safety of repeated courses of epratuzumab therapy in patients with moderate-to-severe systemic lupus erythematosus. Secondary objectives were to assess long-term efficacy and health-related quality of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab450433581f482140e11652dad6ced9
https://pubmed.ncbi.nlm.nih.gov/26316325
Zobrazit plný text záznamu
10
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Autor: Daniel J. Wallace, Vibeke Strand, Frédéric Houssiau, B. Kilgallen, Michelle Petri, Caroline Gordon, Lexy Kelley, Marilyn C. Pike, Kenneth C. Kalunian, S. Bongardt, Anna Barry
Publikováno v: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 73, no. 1, p. 183-190 (2013)
OBJECTIVE: To identify a suitable dosing regimen of the CD22-targeted monoclonal antibody epratuzumab in adults with moderately to severely active systemic lupus erythematosus (SLE). METHODS: A phase IIb, multicentre, randomised controlled study (NCT
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c41350b368609a2618146fd1a58509b
https://pubmed.ncbi.nlm.nih.gov/23313811
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje